Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer’s disease, frontotemporal dementia and progressive supranuclear palsy

OBJECTIVES: This longitudinal study compared emerging plasma biomarkers for neurodegenerative disease between controls, patients with Alzheimer’s disease (AD), Lewy body dementia (LBD), frontotemporal dementia (FTD) and progressive supranuclear palsy (PSP). METHODS: Plasma phosphorylated tau at thre...

Descripción completa

Detalles Bibliográficos
Autores principales: Chouliaras, Leonidas, Thomas, Alan, Malpetti, Maura, Donaghy, Paul, Kane, Joseph, Mak, Elijah, Savulich, George, Prats-Sedano, Maria A, Heslegrave, Amanda J, Zetterberg, Henrik, Su, Li, Rowe, James Benedict, O'Brien, John Tiernan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Neurodegeneration
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148982/
https://www.ncbi.nlm.nih.gov/pubmed/35078917
http://dx.doi.org/10.1136/jnnp-2021-327788

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148982/
https://www.ncbi.nlm.nih.gov/pubmed/35078917
http://dx.doi.org/10.1136/jnnp-2021-327788

Ejemplares similares